OPRELVEKIN: 27 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
27
Total FAERS Reports
8 (29.6%)
Deaths Reported
9
Hospitalizations
27
As Primary/Secondary Suspect
2
Life-Threatening
First Report: 201501 · Latest Report: 20250318
What Are the Most Common OPRELVEKIN Side Effects?
#1 Most Reported
Myelosuppression
6 reports (22.2%)
#2 Most Reported
Hiccups
5 reports (18.5%)
#3 Most Reported
Thrombocytopenia
3 reports (11.1%)
All OPRELVEKIN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Myelosuppression | 6 | 22.2% | 0 | 3 |
| Hiccups | 5 | 18.5% | 0 | 1 |
Who Reports OPRELVEKIN Side Effects? Age & Gender Data
Gender: 30.4% female, 69.6% male. Average age: 51.1 years. Most reports from: CN. View detailed demographics →
Is OPRELVEKIN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2015 | 2 | 0 | 1 |
| 2018 | 1 | 0 | 0 |
| 2021 | 1 | 1 | 1 |
| 2023 | 1 | 0 | 0 |
| 2024 | 1 | 0 | 1 |
| 2025 | 1 | 0 | 1 |
What Is OPRELVEKIN Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 5 |
Official FDA Label for OPRELVEKIN
Official prescribing information from the FDA-approved drug label.